Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Change in Cash: 2023-2025

Historic Change in Cash for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to $36.2 million.

  • Camp4 Therapeutics' Change in Cash rose 459.19% to $36.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.7 million, marking a year-over-year increase of 251.70%. This contributed to the annual value of $25.7 million for FY2024, which is 157.62% up from last year.
  • As of Q3 2025, Camp4 Therapeutics' Change in Cash stood at $36.2 million, which was up 452.48% from -$10.3 million recorded in Q2 2025.
  • Camp4 Therapeutics' Change in Cash's 5-year high stood at $61.5 million during Q4 2024, with a 5-year trough of -$14.7 million in Q1 2025.
  • Its 3-year average for Change in Cash is $3.1 million, with a median of -$10.8 million in 2024.
  • Per our database at Business Quant, Camp4 Therapeutics' Change in Cash surged by 608.82% in 2024 and then declined by 29.54% in 2025.
  • Camp4 Therapeutics' Change in Cash (Quarterly) stood at -$12.1 million in 2023, then spiked by 608.82% to $61.5 million in 2024, then skyrocketed by 459.19% to $36.2 million in 2025.
  • Its last three reported values are $36.2 million in Q3 2025, -$10.3 million for Q2 2025, and -$14.7 million during Q1 2025.